DSM Capital Partners LLC Invests $84,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

DSM Capital Partners LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 249 shares of the medical equipment provider’s stock, valued at approximately $84,000.

A number of other large investors have also modified their holdings of the stock. Baystate Wealth Management LLC grew its stake in shares of Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. MCF Advisors LLC grew its stake in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares in the last quarter. Headinvest LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth $28,000. Stone House Investment Management LLC grew its stake in shares of Intuitive Surgical by 100.0% during the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. Finally, Truvestments Capital LLC grew its stake in shares of Intuitive Surgical by 137.2% during the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 59 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 175 shares of the stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $387.22, for a total transaction of $67,763.50. Following the completion of the transaction, the senior vice president now directly owns 533 shares of the company’s stock, valued at $206,388.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, VP Marshall Mohr sold 108,790 shares of the stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the transaction, the vice president now directly owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 175 shares of the stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $387.22, for a total transaction of $67,763.50. Following the transaction, the senior vice president now directly owns 533 shares of the company’s stock, valued at $206,388.26. The disclosure for this sale can be found here. Insiders sold 148,290 shares of company stock valued at $57,207,154 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 1.6 %

Shares of ISRG traded up $6.46 during mid-day trading on Friday, hitting $404.85. 1,082,160 shares of the company’s stock were exchanged, compared to its average volume of 1,036,880. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $408.43. The firm has a market capitalization of $143.60 billion, a P/E ratio of 73.08, a P/E/G ratio of 5.23 and a beta of 1.39. The business’s 50 day moving average is $386.45 and its two-hundred day moving average is $362.65.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.00 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. BTIG Research boosted their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Piper Sandler upped their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research note on Friday, April 19th. Finally, Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $396.17.

View Our Latest Stock Analysis on ISRG

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.